Cerebrospinal fluid and serum MHPG improve Alzheimer's disease versus dementia with Lewy bodies differential diagnosis

INTRODUCTION: Given the challenges concerning the differential diagnosis of dementia, we investigated the possible added value of monoaminergic compounds to the standard cerebrospinal fluid (CSF) Alzheimer's disease (AD) biomarkers. Particularly, regarding the AD versus dementia with Lewy bodie...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Alzheimers Dement (Amst)
Autores principales: Janssens, Jana, Vermeiren, Yannick, Fransen, Erik, Aerts, Tony, Van Dam, Debby, Engelborghs, Sebastiaan, De Deyn, Peter P.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2018
Materias:
Blood-Based Biomarkers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5852321/
https://ncbi.nlm.nih.gov/pubmed/29552632
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2018.01.002
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares